These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3691130)

  • 1. Propionohydroxamic acid in the treatment of urease-induced calculi. Six months follow-up of 19 patients.
    Tizzani A; Casetta G; Piana P; Carone R; Giona C; Rocca Rossetti S
    Contrib Nephrol; 1987; 58():212-4. PubMed ID: 3691130
    [No Abstract]   [Full Text] [Related]  

  • 2. Urease inhibition in the treatment of infected renal stones: propionohydroxamic acid.
    Martelli A; Buli P; Cortecchia V; Spatafora S; Fiore F; Tiozzi E
    Contrib Nephrol; 1987; 58():196-200. PubMed ID: 3691126
    [No Abstract]   [Full Text] [Related]  

  • 3. Physicochemical changes of urine environment on propionhydroxamic acid therapy.
    Bruno M; Marangella M; Tricerri A; Martini C; Linari F
    Contrib Nephrol; 1987; 58():207-11. PubMed ID: 3691128
    [No Abstract]   [Full Text] [Related]  

  • 4. Propionhydroxamic acid in the management of struvite urinary stones.
    Puppo P; Germinale F; Bottino P; Ricciotti G; Giuliani L
    Contrib Nephrol; 1987; 58():201-6. PubMed ID: 3691127
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi.
    Griffith DP; Gibson JR; Clinton CW; Musher DM
    J Urol; 1978 Jan; 119(1):9-15. PubMed ID: 23442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection stones and the role of bacterial urease.
    Rosenstein I; Hamilton-Miller JM; Brumfitt W
    J Infect; 1980 Sep; 2(3):211-4. PubMed ID: 6764484
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitors of urease as chemotherapeutic agents.
    Rosenstein IJ; Hamilton-Miller JM
    Crit Rev Microbiol; 1984; 11(1):1-12. PubMed ID: 6373150
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of a urease inhibitor, propionohydroxamic acid, in the treatment and prevention of infectious renal lithiasis. A study of 19 patients].
    Tizzani A; Casetta G; Giona C; Piana P; Frea B
    Minerva Urol Nefrol; 1986; 38(3):239-49. PubMed ID: 3810384
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acetylhydroxamic acid in the treatment of nephrolithiasis, caused by infection with urease forming microorganisms].
    Lorenz J; Lorenz K; Dabrowska B; Kowal R
    Z Urol Nephrol; 1989 Dec; 82(12):685-9. PubMed ID: 2698024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benurestat, a urease inhibitor for the therapy of infected ureolysis.
    Andersen JA
    Invest Urol; 1975 Mar; 12(5):381-6. PubMed ID: 1089613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary calculi and infection].
    Trinchieri A
    Urologia; 2014; 81(2):93-8. PubMed ID: 24874306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal cord injury patients.
    Griffith DP; Khonsari F; Skurnick JH; James KE
    J Urol; 1988 Aug; 140(2):318-24. PubMed ID: 3294442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral acetohydroxamic acid on urinary saturation in stone-forming spinal cord patients.
    Burr RG; Nuseibeh I
    Br J Urol; 1983 Apr; 55(2):162-5. PubMed ID: 6839086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of infected urinary stones by urease inhibition.
    Griffith DP; Musher DM
    Invest Urol; 1973 Nov; 11(3):228-33. PubMed ID: 4584162
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose propionhydroxamic acid therapy in infection-induced stones.
    Colussi G; Surian M; De Ferrari ME; Rombolà G; Rolando P; Minetti L
    Contrib Nephrol; 1987; 58():230-2. PubMed ID: 3691134
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of infected urinary stones in rats by a new hydroxamic acid, "N-(pivaloyl)glycinohydroxamic acid.
    Takeuchi H; Okada Y; Kobashi K; Yoshida O
    Urol Res; 1982; 10(4):217-9. PubMed ID: 6758273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary calculi: microbiological and crystallographic studies.
    Rosenstein IJ
    Crit Rev Clin Lab Sci; 1986; 23(3):245-77. PubMed ID: 3524996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance and side effects of propionhydroxamic acid.
    Di Silverio F; Gallucci M; Alpi G; Ricciuti GP; Fini D; Molinari C
    Contrib Nephrol; 1987; 58():215-8. PubMed ID: 3691131
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of bacterial urease.
    Griffith DP; Musher DM; Campbell JW
    Invest Urol; 1973 Nov; 11(3):234-8. PubMed ID: 4201416
    [No Abstract]   [Full Text] [Related]  

  • 20. S.E.M. study of urease-induced crystalluria in the presence of hydroxamic derivatives.
    Ben Amar M; L'Espérance G; Tawashi R
    Int Urol Nephrol; 1986; 18(3):227-33. PubMed ID: 3771124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.